首页 > 市场调查报告书 > 工业机械

市场调查报告书

商品编码

1643903

全球灭菌服务市场 - 2025-2033

Global Sterilization Services Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球灭菌服务市场在2024年达到38亿美元，预计2033年将达到65.3亿美元，在2025-2033年预测期间复合年增长率为6.4%。

灭菌服务是医疗保健系统的重要组成部分，因为它们确保医疗器械和设备在用于患者之前不含活细菌。这项技术对于预防感染至关重要，特别是在病原体容易传播的手术环境中。消毒服务包括一系列广泛的任务，例如对可重复使用的医疗设备进行清洁、消毒和灭菌，所有这些对于病人安全和护理品质都至关重要。

对灭菌服务不断增长的需求正在推动全球灭菌服务市场的发展。对医院获得性感染的日益担忧以及全球范围内进行的外科手术数量的增加正在增加对绝育服务的需求。随着医疗机构努力提高病患安全并降低感染风险，对有效灭菌技术的需求变得至关重要，这在预测期内推动了市场。

市场动态：

驱动程式和限制

灭菌服务需求增加

对灭菌服务的需求不断增长预计将成为全球灭菌服务市场成长的重要因素。由于外科手术数量的增加以及对医院获得性感染的担忧日益增加，对绝育服务的需求不断增加。

随着外科手术数量的增加，消毒服务的需求越来越大，以便在手术后消毒手术单元和手术器械以控制感染。例如，根据美国国立卫生研究院的数据，据报道，到 2023 年，每年进行约 40 万例 CABG 手术，使其成为最受欢迎的主要外科手术。此外，根据美国国立卫生研究院的数据，到2024 年，髋关节和膝关节置换手术是美国最常见的两种手术，估计有700 万美国人需要进行完整的髋关节或膝关节置换手术，超过100 万例置换手术每年都进行。

院内感染的盛行每年影响数百万患者，导致发病率和医疗支出增加，凸显了严格消毒措施的必要性。医疗保健提供者意识的提高正在推动对可靠灭菌服务的需求，以确保医疗器械和设备在使用前不含有害微生物。因此，随着手术技术的进步和全球医院获得性感染数量的增加，对灭菌服务的需求增加，全球灭菌服务增加市场热潮。

用于灭菌服务的化学製剂的有害影响

用于灭菌服务的化学製剂的有害影响等因素预计将阻碍全球灭菌服务市场。环氧乙烷 (EtO) 通常用于对热敏医疗设备进行消毒，其伴随的健康风险是医疗保健专业人员和患者的主要担忧。接触环氧乙烷会导致许多急性和慢性健康问题，包括呼吸道刺激、头痛，甚至更严重的疾病，如癌症和生殖健康障碍。环氧乙烷被认为是一种已证实的人类致癌物，使其使用变得复杂化，导致审查和监管压力加大，可能会阻碍市场扩张。

有关此报告的更多详细资讯 - 索取样品

Sterilization services are essential components of healthcare systems, as they ensure that medical instruments and devices are free of viable bacteria before being used on patients. This technique is critical for infection prevention, especially in surgical settings where pathogens are easily transmitted. Sterilization services include an extensive list of tasks such as cleaning, disinfecting, and sterilizing reusable medical devices, all of which are critical to patient safety and quality of care.

The increasing demand for sterilization services is driving the global sterilization services market. The rising concerns over hospital-acquired infections and the growing number of surgical procedures performed globally are increasing the demand for sterilization services. As healthcare facilities strive to improve patient safety and reduce infection risks, the need for effective sterilization technologies has grown critical, this drives the market over the forecast period.

Market Dynamics: Drivers & Restraints

Increasing demand for sterilization services

The increasing demand for sterilization services is expected to be a significant factor in the growth of the global sterilization services market. The demand for sterilization services is increasing owing to the increasing number of surgical procedures, and rising concerns over hospital-acquired infections.

As the number of surgical procedures increases, there is an increasing need for sterilization services to sterilize the surgical unit and the surgical instruments after the surgery to control the infections. For instance, according to the National Institute of Health, In 2023, it was reported that around 400,000 CABG operations are conducted each year, making it the most prevalent major surgical procedure. Moreover, according to the National Institute of Health in 2024, hip and knee arthroplasty surgeries are two of the most common procedures performed in the United States, with an estimated 7 million Americans necessitating a complete hip or knee replacement and more than 1 million replacements were performed each year.

The prevalence of hospital-acquired infections, which impact millions of patients each year and contribute to increased morbidity and healthcare expenditures, emphasizes the need for strict sterilization practices. This increased awareness among healthcare providers is driving up demand for dependable sterilization services that ensure medical instruments and devices are free of harmful microbes before use. Thus, as surgical techniques advance and the number of hospital-acquired infections rises globally, the demand for sterilization services increases, and the global sterilization services increase market upsurges.

Harmful effects of chemical agents used for sterilization services

Factors such as the harmful effects of chemical agents used for sterilization services are expected to hamper the global sterilization services market. Ethylene Oxide (EtO) which is commonly used for sterilizing heat-sensitive medical devices, and its accompanying health risks are a major concern for both healthcare professionals and patients. EtO exposure can cause a number of acute and chronic health concerns, including respiratory irritation, headaches, and even more serious illnesses like cancer and reproductive health disorders. The recognition of EtO as a proven human carcinogen complicates its use, resulting in increased scrutiny and regulatory pressures that may hinder market expansion.

For more details on this report - Request for Sample

Segment Analysis

The Global sterilization services Market is segmented based on Method, Type, Mode of Delivery, End-User, And Region.

Gamma Sterilization segment is expected to dominate the global sterilization services market share

Gamma sterilization is anticipated to dominate the global sterilization services market owing to its high efficiency and efficacy in delivering consistent and controlled doses during the sterilizing process and technological advancements. This approach is preferred because it can sterilize a wide range of materials without using heat, making it appropriate for heat-sensitive medical devices. The lack of radioactive sourcing or re-sourcing requirements further helps its popularity by simplifying the logistics required in the sterilizing procedure.

The recent technological advancements in gamma sterilization services are one of the major reasons to make it the most dominating segment. There are recent launches of gamma sterilization services that use advanced working principles for quick and efficient sterilization procedures. For instance, in December 2024, a novel Gamma Irradiation Chamber (GIC) 5000, Cobalt-60, was recently launched at Mumbai University's Department of Biophysics, marking a significant step forward in radiation research. The facility is projected to provide considerable opportunity for researchers in various sectors, including healthcare sterilization, food processing, material science, and radiation chemistry.

Technological advancements and an increasing number of surgical procedures that increase the need for quick and efficient sterilization services increase the demand for gamma sterilization, making this segment the most dominating in the global sterilization services market.

Geographical Analysis

North America is expected to hold a significant position in the global sterilization services market share

North America will likely account for a significant share of the global sterilization services market, owing to the increasing number of surgical procedures, rising concerns over hospital-acquired infections, technological advancements, and recent launches.

The increasing number of surgical procedures in this region drives the market. For instance, in the United States, one in every nine people living in residences reported having at least one surgical treatment by 2023. Individuals aged 65 and older, as well as Medicare beneficiaries, had the greatest rates, with around one in every five reporting having undergone surgery. As the increasing number of surgical procedures the number of hospital-acquired infections rises, which increases the demand for sterilization services in North America.

Moreover, the technological advancements drive the market in this region due to the presence of major players and high healthcare investment towards product research and development. For instance, in March 2024, STERIS has recently developed the Verafit Sterilization Bags and Covers, which are intended to help biopharmaceutical producers comply with the updated GMP Annex 1 criteria. Verafit products are produced with Purefit, a flexible sterilizing wrap that reduces contamination concerns from particles, germs, and chemicals. This design is intended to ensure sterility throughout storage and handling. The technological advancements and the increasing number of surgical procedures increase the demand for sterilization services and drive the market in this region.

Asia Pacific is growing at the fastest pace in the global sterilization services market

The Asia Pacific region is emerging as the fastest-growing market for sterilization services, owing to a combination of demographic trends, an increasing number of surgical procedures, rising concerns over hospital-acquired infections, and technological advancements. The increasing number of surgical procedures in this region drives the market. For instance, according to an article published by the Indian Express, each year, an estimated 30 million surgical procedures are performed in India. Significantly, 85% of surgeries are performed in smaller and mid-sized hospitals, with only 15% taking place in corporate hospitals. An increasing number of surgical procedures increases the number of hospital-acquired infections which increases the demand for sterilization services and makes this region the fastest-growing region.

Competitive Landscape

The major global players in the global sterilization services market are B. Braun Medical Ltd, Stryker Corporation, BGS Beta-Gamma-Service GmbH & Co. KG, E-BEAM Services Inc, Fortive Corporation, Medistri SA, MMM Group, Noxilizer Inc., Sotera Health Company, Steris among others.

Emerging Players

Blue Line Sterilization Services, Microtrol Sterilisation Services Pvt Ltd., and Yashodhan Enterprise among others

Key Developments

In February 2024, Thermo Fisher Scientific has established a new sterile medication facility in Singapore, which will help customers deliver novel medicines and vaccines to the Asia-Pacific market. The new facility features a high-speed, fully automated aseptic fill-finish line for both small and big molecules. This strategic investment in Singapore complements expanded research capabilities at Thermo Fisher Scientific's Customer Experience Center and Bioprocess Design Center, both of which are operational lab facilities that display cutting-edge bioprocessing, life science, and analytical technology.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global sterilization services market report delivers a detailed analysis with 70+ key tables, more than 55 visually impactful figures, and 200 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Method
3.2. Snippet by Type
3.3. Snippet by Mode of Delivery
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Rising Demand for Sterilization Services
- 4.1.3. Restraints
- 4.1.4. Harmful Effects of Chemical Agents Used for the Sterilization Services
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Method

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 6.1.2. Market Attractiveness Index, By Method
6.2. Ethylene Oxide Sterilization*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Gamma Sterilization
6.4. Steam Sterilization
6.5. Electron Beam Radiation Sterilization
6.6. Others

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Contract Sterilization Services*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sterilization Validation Services

8. By Mode of Delivery

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 8.1.2. Market Attractiveness Index, By Mode of Delivery
8.2. Off-Site Sterilization Services*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. On-Site Sterilization Services

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Device Manufacturing Companies
9.4. Pharmaceutical and Biotechnology Companies
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. B. Braun Medical Ltd*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Stryker Corporation
12.3. BGS Beta-Gamma-Service GmbH & Co. KG
12.4. E-BEAM Services Inc
12.5. Fortive Corporation
12.6. Medistri SA
12.7. MMM Group
12.8. Noxilizer Inc.
12.9. Sotera Health Company
12.10. Steris

LIST NOT EXHAUSTIVE